NetworkNewsBreaks – Vivos Therapeutics Inc. (NAS
Post# of 51
Vivos Therapeutics (NASDAQ: VVOS), a medical technology company focused on developing and commercializing innovative treatments for patients suffering from mild-to-moderate obstructive sleep apnea (“OSA”) and snoring, today announced its participation at the H.C. Wainwright 23rd Annual Global Investment Conference. Vivos CEO Kirk Huntsman will be presenting at the event beginning at 7:00 a.m. EDT on Monday, Sept. 13, 2021. Interested institutional or retail investors should visit https://nnw.fm/Ij5AB to register for the conference and may listen to the company’s presentation online at https://nnw.fm/0Cxyt. A replay of the presentation will be available via the Investor Relations page of the company’s website.
Please see full disclaimers on the NetworkNewsWire website applicable to all content provided by NNW, wherever published or re-published: http://NNW.fm/Disclaimer